Soros Fund Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Soros Fund Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,575,001	Closed	-$81.4M	–	339
2022 Q3	$81.4M	Buy	+1,575,001	New	+$65.1M	1.39%	27

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Soros Fund Management's CCXI Position: Q4 2022 in Review

Soros Fund Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 1,575,001 shares — an estimated $81.4M sold.

Soros Fund Management first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $81.4M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Soros Fund Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Soros Fund Management sold 1,575,001 ChemoCentryx, Inc. shares in Q4 2022, an estimated $81.4M.
Soros Fund Management first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
Soros Fund Management's ChemoCentryx, Inc. position peaked at $81.4M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Soros Fund Management's 13F filing for Q4 2022, filed 13 Feb 2023.